ImmunityBio, Inc. (IBRX)

NASDAQ: IBRX · Real-Time Price · USD

8.70

+0.09 (1.05%)

At close: Feb 20, 2026, 4:00 PM EST

8.70

0.00 (-0.02%)

After-hours: Feb 20, 2026, 7:59 PM EST

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States Revenue	-	14.21M	31.00K
United States Revenue Growth	-	45751.61%	-26.19%
Europe Revenue	-	531.00K	591.00K
Europe Revenue Growth	-	-10.15%	198.49%
Revenue (Total)	82.56M	14.75M	622.00K
Revenue (Total) Growth	459.88%	2270.58%	159.17%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Product Revenue	81.92M	14.15M	-
Product Revenue Growth	478.91%	-	-
Other Revenue	639.00K	595.00K	622.00K
Other Revenue Growth	7.40%	-4.34%	159.17%
Revenue (Total)	82.56M	14.75M	622.00K
Revenue (Total) Growth	459.88%	2270.58%	159.17%

Updated Sep 30, 2025. Data Source: Fiscal.ai.